CARDIOLIPIN ANTIBODY (ACL) – IGM

The cardiolipin antibody (aCL) IgM test detects IgM antibodies against cardiolipin, a phospholipid found in cell membranes. This test is also used to diagnose anti-phospholipid syndrome (APS). Elevated levels of aCL IgM antibodies indicate an increased risk of blood clots and help diagnose APS, guiding appropriate treatment to prevent thrombotic events. The test is often performed alongside other aCL tests, such as aCL IgG and aCL IgA, to provide a comprehensive assessment. Identifying aCL antibodies is essential for managing APS and reducing the risk of complications, such as recurrent miscarriages and cardiovascular events.